other material
confidence high
sentiment neutral
materiality 0.75
VivoSim stockholders approve reverse split, equity plan increase, and warrant repricing at annual meeting
VivoSim Labs, INC.
- VivoSim held its 2026 Annual Meeting on Sept. 30, 2026; 6,180,635 shares (37.26%) were represented, a quorum, out of 16,586,495 shares outstanding as of the Aug. 13, 2026 record date.
- Stockholders elected Keith Murphy and Adam Stern as Class III directors, each to serve until the 2029 Annual Meeting; Murphy received 2,070,729 For votes and Stern 2,069,436 For.
- Stockholders approved a reverse stock split at a ratio of 1-to-5 to 1-to-20, exercisable by the Board on or before Sept. 30, 2027, with 74.12% of votes cast in favor.
- Stockholders approved increasing the 2022 Equity Incentive Plan by 3,165,000 shares, with 72.52% of votes cast in favor.
- Stockholders approved issuing 4,705,883 shares upon warrant exercise and reducing the May 13, 2024 warrant exercise price from $9.60 to $0.85; the proposal received 77.87% approval.